MNKD Q4 2018 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M+253.9% YoY

Gross Profit

$10M62.1% margin

Operating Income

-$8M-48.2% margin

Net Income

-$10M-60.8% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+258.7%

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$25M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$108M

Total Liabilities

$283M

Stockholders' Equity

-$175M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$5M	+253.9%
Gross Profit	$10M	-$488,000	+2140.8%
Operating Income	-$8M	-$29M	+73.2%
Net Income	-$10M	-$33M	+70.3%